PPTA Twitter

PlasmaProteins “Today, patients are living longer, more fruitful lives. I want tomorrow to be even brighter for patients, & I am committed to PPTA’s steadfast pledge to this goal.” #PlasmaProteins President & CEO @Efantis shares her excitement about her new role: bit.ly/2PX1A5r pic.twitter.com/goWVeZupoj
About 4 hours ago.
PlasmaProteins It’s important for policymakers to understand the impact of #plasmaprotein therapies. “These are not therapies that provide a small measure of comfort or a little bit of increased ability. These are life-saving and life-changing.” Read John’s story: bit.ly/2KLwONK pic.twitter.com/OYcw1jUyON
2 days ago.

Plasma Protein Therapeutics Association

The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions.

Erica XLA

PPTA works globally to:

    • Advocate for access to and affordability of therapies for patients
    • Engage in constructive dialogue with regulatory agencies
    • Collaborate with patient advocacy organizations

PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients.

Copyright © 2018 PPTA. All rights reserved. (202) 789-3100